Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Detheux responsible for expanding the pipeline and leading development of immuno-oncology programs
July 3, 2018
By: Kristin Brooks
Managing Editor, Contract Pharma
Scott Chappel, Ph.D., has been appointed chief scientific officer, iTeos Therapeutics SA. Dr. Chappel reports to chief executive officer Michel Detheux, Ph.D., and will be responsible for expanding the pipeline and leading the preclinical development of the company’s immuno-oncology programs that target the tumor microenvironment to improve the outcomes for cancer patients. “We are delighted that Scott has joined iTeos as CSO. He has been a leader in the life sciences sector for more than three decades and is an accomplished scientist who has directed research that has led to the development of several FDA-approved and marketed biological products,” said Dr. Detheux of iTeos. “His experience will be invaluable to the next phase of our growth as we build an attractive pipeline and transition our programs into the clinic.” Dr. Chappel has significant biotech experience and a strong scientific research and drug development track record. Prior to joining iTeos, he was a founder and chief technology officer at Surface Oncology, where he oversaw all antibody generation, engineering, production and characterization as well as all preclinical IND-enabling studies and GMP manufacturing of antibodies. He was also a founder and chief scientific officer at Arteaus Therapeutics (acquired by Eli Lilly in 2014) and Tokai Pharmaceuticals, where he worked to develop an oral therapeutic for the treatment of prostate cancer.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !